Theranosis Life Sciences Pvt Ltd
  • Home
  • About Us
    • Media
    • Frequently Asked Questions (FAQ)
  • Blog
  • Research
    • Liquid Biopsy
  • Contact Us
  • Services
    • Privacy Statement
    • Terms of Service
    • Refund Policy
Select Page

New hope for breast cancer patients – CDK inhibitors

by admin | Oct 11, 2017 | Blog, cancer research, FDA Approvals

US FDA approval for Abemaciclib (Verzenio) ushers in new hope for breast cancer patients Abemaciclib works by blocking the function of two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6. These proteins play a role in driving cell multiplication, which is...

Recent Posts

  • Philips Breakthrough Day – Theranosis Showcase
  • New hope for breast cancer patients – CDK inhibitors
  • Welcome to Theranosis Blog

Recent Comments

    Archives

    • January 2018
    • October 2017
    • January 2017

    Categories

    • Blog
    • cancer research
    • conferences
    • FDA Approvals

    Theranosis Life Sciences Pvt Ltd

    Registered Office Address: 4th Floor CRTDH, CCMB Annex II Opp Genpact, Habsiguda, Hyderabad, TS 500039 GSTIN: 36AAFCT6407Q1ZR CIN: U85191TG2016PTC103127

    Categories

    • Blog
    • cancer research
    • conferences
    • FDA Approvals

    Recent Posts

    • Philips Breakthrough Day – Theranosis Showcase
    • New hope for breast cancer patients – CDK inhibitors
    • Welcome to Theranosis Blog
    • Facebook
    • Twitter
    • Google
    • Instagram
    • RSS
    All Rights Reserved | Copyright @ Theranosis Life Sciences Pvt Ltd | 2020